BioCentury
ARTICLE | Clinical News

SCYX-7158: Phase I started

March 19, 2012 7:00 AM UTC

Anacor said the Drugs for Neglected Diseases initiative (Geneva, Switzerland) began a double-blind, placebo-controlled, French Phase I trial to evaluate single and multiple ascending-doses of oral SCYX-7158 in up to 120 healthy male volunteers. ...